EarningsQ3 2024 Earnings Report

Vertex Pharmaceuticals (1VRTX) Q3 2024 Earnings Report

4 Followers

IT:1VRTX Q3 2024 EPS Results

Actual EPS€3.90

Consensus EPS€3.63

Beat/MissBeat by +€0.27

One Year Ago EPS€3.63

Actual Revenue€2.47B

Expected Revenue€2.39B

Beat/MissBeat by +€79.72M

YoY Revenue Growth+11.86%

QuarterQ3 2024

Date11/04/2024

TimeAfter Close

Conference CallMonday, November 4, 2024

IT:1VRTX Upcoming Earnings

Vertex Pharmaceuticals's next earnings date is estimated for November 9, 2026, based on past reporting schedules.

IT:1VRTX Q3 2024 Earnings Call

0:00 / 0:00

No earnings call summary is available for this earnings event.

Report Date	Fiscal Quarter	Forecast / EPS	Last Year's EPS	EPS YoY Change
Nov 09, 2026	2026 (Q3)	4.24 / -	4.274	―
Aug 03, 2026	2026 (Q2)	4.22 / 4.21	4.024	4.65% (+0.19)
May 04, 2026	2026 (Q1)	3.78 / 3.98	3.615	10.10% (+0.37)
Feb 12, 2026	2025 (Q4)	4.55 / 4.48	3.544	26.38% (+0.93)
Nov 03, 2025	2025 (Q3)	4.07 / 4.27	3.9	9.59% (+0.37)
Aug 06, 2025	2025 (Q2)	3.82 / 4.02	-11.423	135.23% (+15.45)
May 05, 2025	2025 (Q1)	3.84 / 3.61	4.238	-14.71% (-0.62)
Feb 10, 2025	2024 (Q4)	3.58 / 3.54	3.74	-5.24% (-0.20)
Nov 04, 2024	2024 (Q3)	3.63 / 3.90	3.633	7.35% (+0.27)
Aug 01, 2024	2024 (Q2)	-10.35 / -11.42	3.464	-429.82% (-14.89)

The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

Beat

Missed